Subnetwork | Dataset | Score | p-value 1 | p-value 2 | p-value 3 | Size | Highlighted genes |
---|---|---|---|---|---|---|---|
int-snw-10980 | chia-screen-data-Fav | 2.797 | 4.21e-15 | 7.56e-04 | 4.65e-03 | 12 | 8 |
reg-snw-3145 | chia-screen-data-Fav | 2.226 | 2.10e-07 | 3.98e-02 | 3.04e-02 | 23 | 17 |
int-snw-6334 | chia-screen-data-Fav | 2.813 | 2.82e-15 | 6.25e-04 | 4.06e-03 | 16 | 14 |
Gene Symbol | Entrez Gene ID | Frequency | chia-screen-data-Fav gene score | Best subnetwork score | Degree | Chia-Hits Primary | Chia-Hits Secondary |
---|---|---|---|---|---|---|---|
EP300 | 2033 | 2 | -2.274 | 3.120 | 415 | Yes | Yes |
ANAPC5 | 51433 | 6 | -1.264 | 2.263 | 239 | - | - |
CNOT1 | 23019 | 7 | -2.347 | 2.263 | 124 | Yes | - |
PHB2 | 11331 | 6 | -2.236 | 2.994 | 151 | Yes | - |
SCN8A | 6334 | 3 | -1.173 | 2.813 | 5 | - | - |
PHB | 5245 | 12 | -2.743 | 2.689 | 163 | Yes | Yes |
REXO4 | 57109 | 3 | -1.743 | 2.287 | 95 | - | - |
ICT1 | 3396 | 3 | -2.210 | 2.813 | 208 | Yes | - |
MED13L | 23389 | 8 | -2.550 | 2.307 | 50 | Yes | - |
APC | 324 | 6 | -2.293 | 3.004 | 384 | Yes | - |
HMOX2 | 3163 | 2 | -2.116 | 2.797 | 36 | Yes | - |
POU5F1 | 5460 | 12 | -5.148 | 3.538 | 179 | Yes | Yes |
GSTP1 | 2950 | 3 | -2.251 | 2.955 | 59 | Yes | - |
MAPK14 | 1432 | 3 | -1.902 | 2.955 | 304 | - | - |
KLHL8 | 57563 | 2 | -1.993 | 2.797 | 35 | - | - |
PSMD2 | 5708 | 6 | -4.172 | 3.157 | 389 | Yes | Yes |
EIF2S2 | 8894 | 9 | -2.999 | 2.459 | 103 | Yes | Yes |
FBXL6 | 26233 | 5 | -2.253 | 2.689 | 22 | Yes | - |
SUV39H2 | 79723 | 7 | -2.307 | 2.410 | 21 | Yes | Yes |
COPS4 | 51138 | 2 | -3.198 | 3.043 | 62 | Yes | Yes |
COPS3 | 8533 | 5 | -1.873 | 2.435 | 118 | - | - |
CLPP | 8192 | 3 | -2.200 | 2.291 | 10 | Yes | - |
CCT7 | 10574 | 10 | -2.335 | 2.459 | 173 | Yes | - |
HNRNPU | 3192 | 12 | -2.869 | 2.644 | 172 | Yes | - |
ZNRD1 | 30834 | 3 | -1.375 | 2.226 | 106 | - | - |
TMEM14B | 81853 | 3 | -2.879 | 2.226 | 6 | Yes | Yes |
NDUFA4L2 | 56901 | 10 | -2.477 | 2.459 | 21 | Yes | - |
CENPA | 1058 | 5 | -2.185 | 2.393 | 205 | Yes | - |
COPS2 | 9318 | 2 | -2.531 | 3.043 | 46 | Yes | - |
YAP1 | 10413 | 12 | -4.256 | 3.538 | 53 | Yes | - |
SNAP23 | 8773 | 3 | -2.073 | 2.430 | 15 | Yes | - |
TADA2B | 93624 | 4 | -3.061 | 3.082 | 19 | Yes | - |
POLR2E | 5434 | 5 | -2.037 | 2.644 | 316 | Yes | - |
NOD2 | 64127 | 2 | -1.921 | 2.797 | 26 | - | - |
EIF2B2 | 8892 | 4 | -2.462 | 2.968 | 95 | Yes | Yes |
HMBS | 3145 | 3 | -1.117 | 2.226 | 22 | - | - |
EIF2B3 | 8891 | 5 | -2.546 | 2.435 | 13 | Yes | Yes |
COPS6 | 10980 | 3 | -1.765 | 2.393 | 157 | - | - |
GPS1 | 2873 | 10 | -3.621 | 2.689 | 62 | Yes | Yes |
DDIT3 | 1649 | 11 | -2.825 | 3.504 | 343 | Yes | Yes |
FUBP1 | 8880 | 6 | -2.414 | 2.389 | 41 | Yes | Yes |
Gene Symbol 1 | Entrez Gene ID 1 | Gene Symbol 2 | Entrez Gene ID 2 | Type | Direction | Origin databases / Sources |
---|---|---|---|---|---|---|
CENPA | 1058 | ZNRD1 | 30834 | pd | <> | reg.ITFP.txt: no annot |
CCT7 | 10574 | REXO4 | 57109 | pd | < | reg.ITFP.txt: no annot |
MAPK14 | 1432 | DDIT3 | 1649 | pp | -- | int.I2D: BCI, BioGrid, HPRD; int.HPRD: in vitro |
CCT7 | 10574 | ZNRD1 | 30834 | pd | < | reg.ITFP.txt: no annot |
MAPK14 | 1432 | GSTP1 | 2950 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct, BCI |
EP300 | 2033 | COPS6 | 10980 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: BioGrid, HPRD, IntAct, StelzlMedium; int.HPRD: yeast 2-hybrid |
GPS1 | 2873 | PHB | 5245 | pd | > | reg.ITFP.txt: no annot |
APC | 324 | CCT7 | 10574 | pp | -- | int.I2D: Jorgensen_EphR, SOURAV_MAPK_LOW, IntAct |
EIF2B2 | 8892 | TADA2B | 93624 | pp | -- | int.I2D: BioGrid_Fly, BIND_Fly, FlyLow, IntAct_Fly, MINT_Fly |
APC | 324 | PHB | 5245 | pp | -- | int.I2D: Jorgensen_EphR |
ICT1 | 3396 | PHB | 5245 | pp | -- | int.I2D: BioGrid |
POLR2E | 5434 | ANAPC5 | 51433 | pd | <> | reg.ITFP.txt: no annot |
COPS6 | 10980 | KLHL8 | 57563 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: BioGrid, IntAct |
HNRNPU | 3192 | ANAPC5 | 51433 | pd | < | reg.ITFP.txt: no annot |
COPS3 | 8533 | COPS6 | 10980 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: BioGrid, BIND, HPRD, IntAct, BCI, INNATEDB, MGI; int.HPRD: in vitro; int.DIP: MI:0915(physical association) |
COPS6 | 10980 | COPS4 | 51138 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: BioGrid, BioGrid_Fly, BIND_Fly, FlyLow, HPRD, IntAct, IntAct_Fly, BIND, MGI, MINT_Fly; int.HPRD: in vitro |
PSMD2 | 5708 | CNOT1 | 23019 | pp | -- | int.I2D: YeastLow |
CNOT1 | 23019 | ANAPC5 | 51433 | pd | < | reg.ITFP.txt: no annot |
COPS3 | 8533 | COPS2 | 9318 | pp | -- | int.I2D: BioGrid, BCI, HPRD, INNATEDB, MGI; int.HPRD: in vitro; int.DIP: MI:0915(physical association) |
HMOX2 | 3163 | COPS6 | 10980 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: BioGrid, HPRD, MINT, StelzlMedium, IntAct; int.Mint: MI:0915(physical association); int.HPRD: yeast 2-hybrid |
GPS1 | 2873 | COPS6 | 10980 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct, BioGrid, HPRD, MGI; int.HPRD: in vitro |
HMBS | 3145 | COPS3 | 8533 | pd | < | reg.ITFP.txt: no annot |
GPS1 | 2873 | COPS4 | 51138 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: BIND, IntAct, MGI |
CENPA | 1058 | SUV39H2 | 79723 | pd | > | reg.ITFP.txt: no annot |
POLR2E | 5434 | SNAP23 | 8773 | pd | > | reg.ITFP.txt: no annot |
PHB | 5245 | PHB2 | 11331 | pp | -- | int.I2D: BioGrid, BioGrid_Yeast, IntAct_Yeast |
CENPA | 1058 | FBXL6 | 26233 | pd | > | reg.ITFP.txt: no annot |
HMBS | 3145 | REXO4 | 57109 | pd | < | reg.ITFP.txt: no annot |
HMBS | 3145 | ZNRD1 | 30834 | pd | < | reg.ITFP.txt: no annot |
DDIT3 | 1649 | HNRNPU | 3192 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
CENPA | 1058 | HMBS | 3145 | pd | > | reg.ITFP.txt: no annot |
HMBS | 3145 | ANAPC5 | 51433 | pd | < | reg.ITFP.txt: no annot |
PHB2 | 11331 | ZNRD1 | 30834 | pd | < | reg.ITFP.txt: no annot |
HNRNPU | 3192 | YAP1 | 10413 | pp | -- | int.I2D: HPRD; int.HPRD: in vitro, in vivo |
HNRNPU | 3192 | POU5F1 | 5460 | pp | -- | int.I2D: BioGrid_Mouse, IntAct_Mouse |
GPS1 | 2873 | COPS2 | 9318 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct_Worm, MGI, MINT_Worm, BioGrid_Worm, BIND, BIND_Worm, CORE_1, HPRD, IntAct, INNATEDB; int.HPRD: in vitro, yeast 2-hybrid |
GPS1 | 2873 | CLPP | 8192 | pd | > | reg.ITFP.txt: no annot |
MAPK14 | 1432 | EIF2B2 | 8892 | pp | -- | int.I2D: IntAct, SOURAV_MAPK_LOW |
MAPK14 | 1432 | ANAPC5 | 51433 | pd | < | reg.ITFP.txt: no annot |
DDIT3 | 1649 | EP300 | 2033 | pp | -- | int.Intact: MI:0915(physical association) |
COPS2 | 9318 | COPS4 | 51138 | pp | -- | int.I2D: BIND, HPRD, MGI; int.HPRD: in vitro, in vivo |
COPS6 | 10980 | NOD2 | 64127 | pp | -- | int.I2D: INNATEDB |
MAPK14 | 1432 | FUBP1 | 8880 | pp | -- | int.I2D: BioGrid |
GPS1 | 2873 | COPS3 | 8533 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: HPRD, IntAct, INNATEDB, BioGrid, MGI; int.HPRD: in vitro, yeast 2-hybrid |
EIF2B3 | 8891 | EIF2S2 | 8894 | pp | -- | int.I2D: HPRD; int.HPRD: in vitro |
ZNRD1 | 30834 | TMEM14B | 81853 | pd | > | reg.ITFP.txt: no annot |
PHB | 5245 | ZNRD1 | 30834 | pd | < | reg.ITFP.txt: no annot |
PSMD2 | 5708 | CCT7 | 10574 | pp | -- | int.I2D: BioGrid_Yeast |
COPS3 | 8533 | EIF2B3 | 8891 | pd | > | reg.ITFP.txt: no annot |
HMBS | 3145 | COPS6 | 10980 | pd | < | reg.ITFP.txt: no annot |
MAPK14 | 1432 | POLR2E | 5434 | pd | < | reg.ITFP.txt: no annot |
EIF2B2 | 8892 | EIF2S2 | 8894 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast, MINT_Yeast, YeastHigh |
EP300 | 2033 | YAP1 | 10413 | pp | -- | int.I2D: BioGrid |
MED13L | 23389 | ANAPC5 | 51433 | pd | < | reg.ITFP.txt: no annot |
CENPA | 1058 | NDUFA4L2 | 56901 | pd | > | reg.ITFP.txt: no annot |
PSMD2 | 5708 | EIF2B2 | 8892 | pp | -- | int.I2D: IntAct_Yeast |
EP300 | 2033 | HNRNPU | 3192 | pp | -- | int.I2D: BioGrid, HPRD, BCI; int.HPRD: in vitro, in vivo |
DDIT3 | 1649 | GSTP1 | 2950 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
GPS1 | 2873 | PHB2 | 11331 | pd | > | reg.ITFP.txt: no annot |
SNAP23 | 8773 | ANAPC5 | 51433 | pd | < | reg.ITFP.txt: no annot |
EP300 | 2033 | ANAPC5 | 51433 | pp | -- | int.I2D: BioGrid |
MAPK14 | 1432 | NOD2 | 64127 | pp | -- | int.I2D: INNATEDB |
MAPK14 | 1432 | SCN8A | 6334 | pp | -- | int.I2D: HPRD; int.HPRD: in vivo |
ICT1 | 3396 | PHB2 | 11331 | pp | -- | int.I2D: BioGrid |
PHB | 5245 | SCN8A | 6334 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
HNRNPU | 3192 | POLR2E | 5434 | pd | < | reg.ITFP.txt: no annot |
COPS2 | 9318 | COPS6 | 10980 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: BCI, BIND, BioGrid, HPRD, IntAct, MGI; int.HPRD: in vitro |
FUBP1 | 8880 | ANAPC5 | 51433 | pd | <> | reg.ITFP.txt: no annot |
CLPP | 8192 | COPS6 | 10980 | pd | < | reg.ITFP.txt: no annot |
COPS3 | 8533 | COPS4 | 51138 | pp | -- | int.I2D: BIND, HPRD, BioGrid, INNATEDB, MGI; int.HPRD: in vitro, in vivo; int.DIP: MI:0915(physical association) |
PSMD2 | 5708 | PHB2 | 11331 | pp | -- | int.I2D: IntAct_Yeast |
Accession number | Name | Hypergeometric test | Corrected p-value | Enrichment ratio | Occurrence in subnetwork | Occurrences in all snw genes | Occurrences in all int/reg genes |
---|---|---|---|---|---|---|---|
GO:0010388 | cullin deneddylation | 9.72e-12 | 1.59e-07 | 7.789 | 5 | 5 | 9 |
GO:0008180 | COP9 signalosome | 2.19e-10 | 3.57e-06 | 6.134 | 6 | 6 | 34 |
GO:0005515 | protein binding | 1.62e-05 | 2.65e-01 | 0.914 | 29 | 77 | 6127 |
GO:0010467 | gene expression | 3.34e-05 | 5.45e-01 | 2.421 | 9 | 27 | 669 |
GO:0051716 | cellular response to stimulus | 3.68e-05 | 6.01e-01 | 7.637 | 2 | 2 | 4 |
GO:0005654 | nucleoplasm | 5.74e-05 | 9.37e-01 | 2.000 | 11 | 31 | 1095 |
GO:0005829 | cytosol | 6.91e-05 | 1.00e+00 | 1.401 | 17 | 38 | 2562 |
GO:0005851 | eukaryotic translation initiation factor 2B complex | 9.18e-05 | 1.00e+00 | 7.052 | 2 | 3 | 6 |
GO:0032495 | response to muramyl dipeptide | 2.19e-04 | 1.00e+00 | 6.467 | 2 | 2 | 9 |
GO:0003743 | translation initiation factor activity | 2.50e-04 | 1.00e+00 | 4.607 | 3 | 5 | 49 |
GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway | 2.74e-04 | 1.00e+00 | 6.315 | 2 | 2 | 10 |
GO:0001054 | RNA polymerase I activity | 3.34e-04 | 1.00e+00 | 6.177 | 2 | 2 | 11 |
GO:0005736 | DNA-directed RNA polymerase I complex | 4.00e-04 | 1.00e+00 | 6.052 | 2 | 2 | 12 |
GO:0042789 | mRNA transcription from RNA polymerase II promoter | 4.72e-04 | 1.00e+00 | 5.936 | 2 | 2 | 13 |
GO:0043409 | negative regulation of MAPK cascade | 4.72e-04 | 1.00e+00 | 5.936 | 2 | 2 | 13 |
GO:0044212 | transcription regulatory region DNA binding | 8.71e-04 | 1.00e+00 | 3.219 | 4 | 5 | 171 |
GO:0006778 | porphyrin-containing compound metabolic process | 9.18e-04 | 1.00e+00 | 5.467 | 2 | 2 | 18 |
GO:0014003 | oligodendrocyte development | 1.14e-03 | 1.00e+00 | 5.315 | 2 | 3 | 20 |
GO:0090090 | negative regulation of canonical Wnt signaling pathway | 1.39e-03 | 1.00e+00 | 3.762 | 3 | 4 | 88 |
GO:0008135 | translation factor activity, nucleic acid binding | 1.64e-03 | 1.00e+00 | 5.052 | 2 | 2 | 24 |
GO:0032720 | negative regulation of tumor necrosis factor production | 2.08e-03 | 1.00e+00 | 4.882 | 2 | 2 | 27 |
GO:0030331 | estrogen receptor binding | 2.08e-03 | 1.00e+00 | 4.882 | 2 | 2 | 27 |
GO:0002367 | cytokine production involved in immune response | 2.51e-03 | 1.00e+00 | 8.637 | 1 | 1 | 1 |
GO:0070126 | mitochondrial translational termination | 2.51e-03 | 1.00e+00 | 8.637 | 1 | 1 | 1 |
GO:1901985 | positive regulation of protein acetylation | 2.51e-03 | 1.00e+00 | 8.637 | 1 | 1 | 1 |
GO:2000016 | negative regulation of determination of dorsal identity | 2.51e-03 | 1.00e+00 | 8.637 | 1 | 1 | 1 |
GO:0043969 | histone H2B acetylation | 2.51e-03 | 1.00e+00 | 8.637 | 1 | 1 | 1 |
GO:0032500 | muramyl dipeptide binding | 2.51e-03 | 1.00e+00 | 8.637 | 1 | 1 | 1 |
GO:0097057 | TRAF2-GSTP1 complex | 2.51e-03 | 1.00e+00 | 8.637 | 1 | 1 | 1 |
GO:0042483 | negative regulation of odontogenesis | 2.51e-03 | 1.00e+00 | 8.637 | 1 | 1 | 1 |
GO:0060795 | cell fate commitment involved in formation of primary germ layer | 2.51e-03 | 1.00e+00 | 8.637 | 1 | 1 | 1 |
GO:0071608 | macrophage inflammatory protein-1 alpha production | 2.51e-03 | 1.00e+00 | 8.637 | 1 | 1 | 1 |
GO:0016150 | translation release factor activity, codon nonspecific | 2.51e-03 | 1.00e+00 | 8.637 | 1 | 1 | 1 |
GO:0051171 | regulation of nitrogen compound metabolic process | 2.51e-03 | 1.00e+00 | 8.637 | 1 | 1 | 1 |
GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration | 2.51e-03 | 1.00e+00 | 8.637 | 1 | 1 | 1 |
GO:0004418 | hydroxymethylbilane synthase activity | 2.51e-03 | 1.00e+00 | 8.637 | 1 | 1 | 1 |
GO:0046645 | positive regulation of gamma-delta T cell activation | 2.51e-03 | 1.00e+00 | 8.637 | 1 | 1 | 1 |
GO:0070664 | negative regulation of leukocyte proliferation | 2.51e-03 | 1.00e+00 | 8.637 | 1 | 1 | 1 |
GO:0035732 | nitric oxide storage | 2.51e-03 | 1.00e+00 | 8.637 | 1 | 1 | 1 |
GO:0032498 | detection of muramyl dipeptide | 2.51e-03 | 1.00e+00 | 8.637 | 1 | 1 | 1 |
GO:0090308 | regulation of methylation-dependent chromatin silencing | 2.51e-03 | 1.00e+00 | 8.637 | 1 | 1 | 1 |
GO:0090081 | regulation of heart induction by regulation of canonical Wnt signaling pathway | 2.51e-03 | 1.00e+00 | 8.637 | 1 | 1 | 1 |
GO:0002710 | negative regulation of T cell mediated immunity | 2.51e-03 | 1.00e+00 | 8.637 | 1 | 1 | 1 |
GO:0070026 | nitric oxide binding | 2.51e-03 | 1.00e+00 | 8.637 | 1 | 1 | 1 |
GO:0060177 | regulation of angiotensin metabolic process | 2.51e-03 | 1.00e+00 | 8.637 | 1 | 1 | 1 |
GO:0035731 | dinitrosyl-iron complex binding | 2.51e-03 | 1.00e+00 | 8.637 | 1 | 1 | 1 |
GO:0018160 | peptidyl-pyrromethane cofactor linkage | 2.51e-03 | 1.00e+00 | 8.637 | 1 | 1 | 1 |
GO:0038066 | p38MAPK cascade | 2.51e-03 | 1.00e+00 | 8.637 | 1 | 1 | 1 |
GO:0002732 | positive regulation of dendritic cell cytokine production | 2.51e-03 | 1.00e+00 | 8.637 | 1 | 1 | 1 |
GO:0035730 | S-nitrosoglutathione binding | 2.51e-03 | 1.00e+00 | 8.637 | 1 | 1 | 1 |
GO:2000629 | negative regulation of miRNA metabolic process | 2.51e-03 | 1.00e+00 | 8.637 | 1 | 1 | 1 |
GO:2000363 | positive regulation of prostaglandin-E synthase activity | 2.51e-03 | 1.00e+00 | 8.637 | 1 | 1 | 1 |
GO:0032701 | negative regulation of interleukin-18 production | 2.51e-03 | 1.00e+00 | 8.637 | 1 | 1 | 1 |
GO:0007094 | mitotic spindle assembly checkpoint | 2.73e-03 | 1.00e+00 | 4.683 | 2 | 3 | 31 |
GO:0005634 | nucleus | 2.93e-03 | 1.00e+00 | 0.792 | 21 | 55 | 4828 |
GO:0042552 | myelination | 3.67e-03 | 1.00e+00 | 4.467 | 2 | 2 | 36 |
GO:0006366 | transcription from RNA polymerase II promoter | 4.05e-03 | 1.00e+00 | 2.227 | 5 | 14 | 425 |
GO:0006413 | translational initiation | 4.31e-03 | 1.00e+00 | 3.188 | 3 | 4 | 131 |
GO:0009408 | response to heat | 4.52e-03 | 1.00e+00 | 4.315 | 2 | 2 | 40 |
GO:0035019 | somatic stem cell maintenance | 4.52e-03 | 1.00e+00 | 4.315 | 2 | 2 | 40 |
GO:0007519 | skeletal muscle tissue development | 4.75e-03 | 1.00e+00 | 4.279 | 2 | 2 | 41 |
GO:0060242 | contact inhibition | 5.02e-03 | 1.00e+00 | 7.637 | 1 | 1 | 2 |
GO:0035419 | activation of MAPK activity involved in innate immune response | 5.02e-03 | 1.00e+00 | 7.637 | 1 | 1 | 2 |
GO:0000939 | condensed chromosome inner kinetochore | 5.02e-03 | 1.00e+00 | 7.637 | 1 | 1 | 2 |
GO:0090043 | regulation of tubulin deacetylation | 5.02e-03 | 1.00e+00 | 7.637 | 1 | 1 | 2 |
GO:0060965 | negative regulation of gene silencing by miRNA | 5.02e-03 | 1.00e+00 | 7.637 | 1 | 1 | 2 |
GO:0035984 | cellular response to trichostatin A | 5.02e-03 | 1.00e+00 | 7.637 | 1 | 1 | 2 |
GO:0004392 | heme oxygenase (decyclizing) activity | 5.02e-03 | 1.00e+00 | 7.637 | 1 | 1 | 2 |
GO:0044324 | regulation of transcription involved in anterior/posterior axis specification | 5.02e-03 | 1.00e+00 | 7.637 | 1 | 1 | 2 |
GO:0009368 | endopeptidase Clp complex | 5.02e-03 | 1.00e+00 | 7.637 | 1 | 1 | 2 |
GO:0009890 | negative regulation of biosynthetic process | 5.02e-03 | 1.00e+00 | 7.637 | 1 | 1 | 2 |
GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process | 5.02e-03 | 1.00e+00 | 7.637 | 1 | 1 | 2 |
GO:0002176 | male germ cell proliferation | 5.02e-03 | 1.00e+00 | 7.637 | 1 | 1 | 2 |
GO:0009786 | regulation of asymmetric cell division | 5.02e-03 | 1.00e+00 | 7.637 | 1 | 1 | 2 |
GO:0019207 | kinase regulator activity | 5.02e-03 | 1.00e+00 | 7.637 | 1 | 1 | 2 |
GO:0071389 | cellular response to mineralocorticoid stimulus | 5.02e-03 | 1.00e+00 | 7.637 | 1 | 1 | 2 |
GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress | 5.02e-03 | 1.00e+00 | 7.637 | 1 | 1 | 2 |
GO:0006788 | heme oxidation | 5.02e-03 | 1.00e+00 | 7.637 | 1 | 1 | 2 |
GO:0014737 | positive regulation of muscle atrophy | 5.02e-03 | 1.00e+00 | 7.637 | 1 | 1 | 2 |
GO:0006965 | positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria | 5.02e-03 | 1.00e+00 | 7.637 | 1 | 1 | 2 |
GO:0009798 | axis specification | 5.02e-03 | 1.00e+00 | 7.637 | 1 | 1 | 2 |
GO:0043434 | response to peptide hormone | 5.94e-03 | 1.00e+00 | 4.113 | 2 | 2 | 46 |
GO:0006974 | cellular response to DNA damage stimulus | 7.25e-03 | 1.00e+00 | 2.918 | 3 | 4 | 158 |
GO:0007254 | JNK cascade | 7.26e-03 | 1.00e+00 | 3.964 | 2 | 2 | 51 |
GO:0071638 | negative regulation of monocyte chemotactic protein-1 production | 7.52e-03 | 1.00e+00 | 7.052 | 1 | 1 | 3 |
GO:0018076 | N-terminal peptidyl-lysine acetylation | 7.52e-03 | 1.00e+00 | 7.052 | 1 | 1 | 3 |
GO:0071459 | protein localization to chromosome, centromeric region | 7.52e-03 | 1.00e+00 | 7.052 | 1 | 1 | 3 |
GO:0010560 | positive regulation of glycoprotein biosynthetic process | 7.52e-03 | 1.00e+00 | 7.052 | 1 | 1 | 3 |
GO:0009595 | detection of biotic stimulus | 7.52e-03 | 1.00e+00 | 7.052 | 1 | 1 | 3 |
GO:0034136 | negative regulation of toll-like receptor 2 signaling pathway | 7.52e-03 | 1.00e+00 | 7.052 | 1 | 1 | 3 |
GO:0004045 | aminoacyl-tRNA hydrolase activity | 7.52e-03 | 1.00e+00 | 7.052 | 1 | 1 | 3 |
GO:0036123 | histone H3-K9 dimethylation | 7.52e-03 | 1.00e+00 | 7.052 | 1 | 1 | 3 |
GO:0090022 | regulation of neutrophil chemotaxis | 7.52e-03 | 1.00e+00 | 7.052 | 1 | 1 | 3 |
GO:0000338 | protein deneddylation | 7.52e-03 | 1.00e+00 | 7.052 | 1 | 1 | 3 |
GO:0035726 | common myeloid progenitor cell proliferation | 7.52e-03 | 1.00e+00 | 7.052 | 1 | 1 | 3 |
GO:0071225 | cellular response to muramyl dipeptide | 7.52e-03 | 1.00e+00 | 7.052 | 1 | 1 | 3 |
GO:0005850 | eukaryotic translation initiation factor 2 complex | 7.52e-03 | 1.00e+00 | 7.052 | 1 | 2 | 3 |
GO:0090400 | stress-induced premature senescence | 7.52e-03 | 1.00e+00 | 7.052 | 1 | 1 | 3 |
GO:0003130 | BMP signaling pathway involved in heart induction | 7.52e-03 | 1.00e+00 | 7.052 | 1 | 1 | 3 |
GO:0060585 | positive regulation of prostaglandin-endoperoxide synthase activity | 7.52e-03 | 1.00e+00 | 7.052 | 1 | 1 | 3 |
GO:0000775 | chromosome, centromeric region | 7.54e-03 | 1.00e+00 | 3.936 | 2 | 3 | 52 |
GO:0044267 | cellular protein metabolic process | 7.66e-03 | 1.00e+00 | 2.008 | 5 | 7 | 495 |
GO:0051403 | stress-activated MAPK cascade | 8.11e-03 | 1.00e+00 | 3.882 | 2 | 2 | 54 |
GO:0003682 | chromatin binding | 9.61e-03 | 1.00e+00 | 2.253 | 4 | 7 | 334 |
GO:0008013 | beta-catenin binding | 9.94e-03 | 1.00e+00 | 3.730 | 2 | 4 | 60 |
GO:0000778 | condensed nuclear chromosome kinetochore | 1.00e-02 | 1.00e+00 | 6.637 | 1 | 1 | 4 |
GO:0097157 | pre-mRNA intronic binding | 1.00e-02 | 1.00e+00 | 6.637 | 1 | 1 | 4 |
GO:0060913 | cardiac cell fate determination | 1.00e-02 | 1.00e+00 | 6.637 | 1 | 1 | 4 |
GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process | 1.00e-02 | 1.00e+00 | 6.637 | 1 | 1 | 4 |
GO:0046523 | S-methyl-5-thioribose-1-phosphate isomerase activity | 1.00e-02 | 1.00e+00 | 6.637 | 1 | 1 | 4 |
GO:0019887 | protein kinase regulator activity | 1.00e-02 | 1.00e+00 | 6.637 | 1 | 1 | 4 |
GO:0018393 | internal peptidyl-lysine acetylation | 1.00e-02 | 1.00e+00 | 6.637 | 1 | 1 | 4 |
GO:2000110 | negative regulation of macrophage apoptotic process | 1.00e-02 | 1.00e+00 | 6.637 | 1 | 1 | 4 |
GO:0071224 | cellular response to peptidoglycan | 1.00e-02 | 1.00e+00 | 6.637 | 1 | 1 | 4 |
GO:0050871 | positive regulation of B cell activation | 1.00e-02 | 1.00e+00 | 6.637 | 1 | 1 | 4 |
GO:0003714 | transcription corepressor activity | 1.02e-02 | 1.00e+00 | 2.738 | 3 | 5 | 179 |
GO:0032481 | positive regulation of type I interferon production | 1.03e-02 | 1.00e+00 | 3.706 | 2 | 2 | 61 |
GO:0016032 | viral process | 1.09e-02 | 1.00e+00 | 1.882 | 5 | 16 | 540 |
GO:0009749 | response to glucose | 1.12e-02 | 1.00e+00 | 3.637 | 2 | 2 | 64 |
GO:0034146 | toll-like receptor 5 signaling pathway | 1.16e-02 | 1.00e+00 | 3.615 | 2 | 2 | 65 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 1.16e-02 | 1.00e+00 | 3.615 | 2 | 3 | 65 |
GO:0034166 | toll-like receptor 10 signaling pathway | 1.16e-02 | 1.00e+00 | 3.615 | 2 | 2 | 65 |
GO:0070461 | SAGA-type complex | 1.25e-02 | 1.00e+00 | 6.315 | 1 | 2 | 5 |
GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process | 1.25e-02 | 1.00e+00 | 6.315 | 1 | 1 | 5 |
GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor | 1.25e-02 | 1.00e+00 | 6.315 | 1 | 1 | 5 |
GO:0070934 | CRD-mediated mRNA stabilization | 1.25e-02 | 1.00e+00 | 6.315 | 1 | 2 | 5 |
GO:0065004 | protein-DNA complex assembly | 1.25e-02 | 1.00e+00 | 6.315 | 1 | 1 | 5 |
GO:0070431 | nucleotide-binding oligomerization domain containing 2 signaling pathway | 1.25e-02 | 1.00e+00 | 6.315 | 1 | 1 | 5 |
GO:0060298 | positive regulation of sarcomere organization | 1.25e-02 | 1.00e+00 | 6.315 | 1 | 1 | 5 |
GO:0001714 | endodermal cell fate specification | 1.25e-02 | 1.00e+00 | 6.315 | 1 | 1 | 5 |
GO:0043620 | regulation of DNA-templated transcription in response to stress | 1.25e-02 | 1.00e+00 | 6.315 | 1 | 1 | 5 |
GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin | 1.25e-02 | 1.00e+00 | 6.315 | 1 | 1 | 5 |
GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly | 1.25e-02 | 1.00e+00 | 6.315 | 1 | 1 | 5 |
GO:0051525 | NFAT protein binding | 1.25e-02 | 1.00e+00 | 6.315 | 1 | 1 | 5 |
GO:0033600 | negative regulation of mammary gland epithelial cell proliferation | 1.25e-02 | 1.00e+00 | 6.315 | 1 | 1 | 5 |
GO:1901741 | positive regulation of myoblast fusion | 1.25e-02 | 1.00e+00 | 6.315 | 1 | 1 | 5 |
GO:0032057 | negative regulation of translational initiation in response to stress | 1.25e-02 | 1.00e+00 | 6.315 | 1 | 1 | 5 |
GO:0036124 | histone H3-K9 trimethylation | 1.25e-02 | 1.00e+00 | 6.315 | 1 | 1 | 5 |
GO:0002830 | positive regulation of type 2 immune response | 1.25e-02 | 1.00e+00 | 6.315 | 1 | 1 | 5 |
GO:0032025 | response to cobalt ion | 1.25e-02 | 1.00e+00 | 6.315 | 1 | 1 | 5 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 1.33e-02 | 1.00e+00 | 3.508 | 2 | 4 | 70 |
GO:0038123 | toll-like receptor TLR1:TLR2 signaling pathway | 1.37e-02 | 1.00e+00 | 3.487 | 2 | 2 | 71 |
GO:0038124 | toll-like receptor TLR6:TLR2 signaling pathway | 1.37e-02 | 1.00e+00 | 3.487 | 2 | 2 | 71 |
GO:0034162 | toll-like receptor 9 signaling pathway | 1.41e-02 | 1.00e+00 | 3.467 | 2 | 2 | 72 |
GO:0005739 | mitochondrion | 1.44e-02 | 1.00e+00 | 1.414 | 7 | 16 | 1046 |
GO:0034134 | toll-like receptor 2 signaling pathway | 1.45e-02 | 1.00e+00 | 3.447 | 2 | 2 | 73 |
GO:0000785 | chromatin | 1.45e-02 | 1.00e+00 | 3.447 | 2 | 2 | 73 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 1.48e-02 | 1.00e+00 | 3.427 | 2 | 4 | 74 |
GO:0005085 | guanyl-nucleotide exchange factor activity | 1.48e-02 | 1.00e+00 | 3.427 | 2 | 2 | 74 |
GO:0030858 | positive regulation of epithelial cell differentiation | 1.50e-02 | 1.00e+00 | 6.052 | 1 | 1 | 6 |
GO:0050847 | progesterone receptor signaling pathway | 1.50e-02 | 1.00e+00 | 6.052 | 1 | 1 | 6 |
GO:0002381 | immunoglobulin production involved in immunoglobulin mediated immune response | 1.50e-02 | 1.00e+00 | 6.052 | 1 | 1 | 6 |
GO:0046974 | histone methyltransferase activity (H3-K9 specific) | 1.50e-02 | 1.00e+00 | 6.052 | 1 | 1 | 6 |
GO:0032873 | negative regulation of stress-activated MAPK cascade | 1.50e-02 | 1.00e+00 | 6.052 | 1 | 1 | 6 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 1.50e-02 | 1.00e+00 | 1.558 | 6 | 13 | 811 |
GO:0032691 | negative regulation of interleukin-1 beta production | 1.50e-02 | 1.00e+00 | 6.052 | 1 | 1 | 6 |
GO:0006333 | chromatin assembly or disassembly | 1.50e-02 | 1.00e+00 | 6.052 | 1 | 1 | 6 |
GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis | 1.50e-02 | 1.00e+00 | 6.052 | 1 | 1 | 6 |
GO:0060744 | mammary gland branching involved in thelarche | 1.50e-02 | 1.00e+00 | 6.052 | 1 | 1 | 6 |
GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway | 1.50e-02 | 1.00e+00 | 6.052 | 1 | 1 | 6 |
GO:0070937 | CRD-mediated mRNA stability complex | 1.50e-02 | 1.00e+00 | 6.052 | 1 | 2 | 6 |
GO:0008432 | JUN kinase binding | 1.50e-02 | 1.00e+00 | 6.052 | 1 | 1 | 6 |
GO:0042167 | heme catabolic process | 1.50e-02 | 1.00e+00 | 6.052 | 1 | 1 | 6 |
GO:0002862 | negative regulation of inflammatory response to antigenic stimulus | 1.50e-02 | 1.00e+00 | 6.052 | 1 | 1 | 6 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 1.54e-02 | 1.00e+00 | 1.757 | 5 | 10 | 589 |
GO:0035666 | TRIF-dependent toll-like receptor signaling pathway | 1.56e-02 | 1.00e+00 | 3.389 | 2 | 2 | 76 |
GO:0002756 | MyD88-independent toll-like receptor signaling pathway | 1.64e-02 | 1.00e+00 | 3.351 | 2 | 2 | 78 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 1.68e-02 | 1.00e+00 | 3.333 | 2 | 4 | 79 |
GO:0002755 | MyD88-dependent toll-like receptor signaling pathway | 1.72e-02 | 1.00e+00 | 3.315 | 2 | 3 | 80 |
GO:0034138 | toll-like receptor 3 signaling pathway | 1.72e-02 | 1.00e+00 | 3.315 | 2 | 2 | 80 |
GO:0000278 | mitotic cell cycle | 1.73e-02 | 1.00e+00 | 2.000 | 4 | 12 | 398 |
GO:0051353 | positive regulation of oxidoreductase activity | 1.75e-02 | 1.00e+00 | 5.830 | 1 | 1 | 7 |
GO:0032930 | positive regulation of superoxide anion generation | 1.75e-02 | 1.00e+00 | 5.830 | 1 | 1 | 7 |
GO:0002606 | positive regulation of dendritic cell antigen processing and presentation | 1.75e-02 | 1.00e+00 | 5.830 | 1 | 1 | 7 |
GO:0002674 | negative regulation of acute inflammatory response | 1.75e-02 | 1.00e+00 | 5.830 | 1 | 1 | 7 |
GO:0006475 | internal protein amino acid acetylation | 1.75e-02 | 1.00e+00 | 5.830 | 1 | 1 | 7 |
GO:0007091 | metaphase/anaphase transition of mitotic cell cycle | 1.75e-02 | 1.00e+00 | 5.830 | 1 | 1 | 7 |
GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development | 1.75e-02 | 1.00e+00 | 5.830 | 1 | 1 | 7 |
GO:0051988 | regulation of attachment of spindle microtubules to kinetochore | 1.75e-02 | 1.00e+00 | 5.830 | 1 | 1 | 7 |
GO:0032731 | positive regulation of interleukin-1 beta production | 1.75e-02 | 1.00e+00 | 5.830 | 1 | 1 | 7 |
GO:0071222 | cellular response to lipopolysaccharide | 1.76e-02 | 1.00e+00 | 3.297 | 2 | 2 | 81 |
GO:0016071 | mRNA metabolic process | 1.83e-02 | 1.00e+00 | 2.421 | 3 | 8 | 223 |
GO:0006355 | regulation of transcription, DNA-templated | 1.89e-02 | 1.00e+00 | 1.336 | 7 | 13 | 1104 |
GO:0032872 | regulation of stress-activated MAPK cascade | 1.99e-02 | 1.00e+00 | 5.637 | 1 | 1 | 8 |
GO:0042582 | azurophil granule | 1.99e-02 | 1.00e+00 | 5.637 | 1 | 1 | 8 |
GO:0045670 | regulation of osteoclast differentiation | 1.99e-02 | 1.00e+00 | 5.637 | 1 | 1 | 8 |
GO:0042754 | negative regulation of circadian rhythm | 1.99e-02 | 1.00e+00 | 5.637 | 1 | 1 | 8 |
GO:0001955 | blood vessel maturation | 1.99e-02 | 1.00e+00 | 5.637 | 1 | 1 | 8 |
GO:0006903 | vesicle targeting | 1.99e-02 | 1.00e+00 | 5.637 | 1 | 1 | 8 |
GO:0000780 | condensed nuclear chromosome, centromeric region | 1.99e-02 | 1.00e+00 | 5.637 | 1 | 1 | 8 |
GO:0001055 | RNA polymerase II activity | 1.99e-02 | 1.00e+00 | 5.637 | 1 | 1 | 8 |
GO:0050700 | CARD domain binding | 1.99e-02 | 1.00e+00 | 5.637 | 1 | 1 | 8 |
GO:0010831 | positive regulation of myotube differentiation | 1.99e-02 | 1.00e+00 | 5.637 | 1 | 1 | 8 |
GO:0016779 | nucleotidyltransferase activity | 1.99e-02 | 1.00e+00 | 5.637 | 1 | 1 | 8 |
GO:0006412 | translation | 2.10e-02 | 1.00e+00 | 2.345 | 3 | 5 | 235 |
GO:0045892 | negative regulation of transcription, DNA-templated | 2.13e-02 | 1.00e+00 | 1.909 | 4 | 7 | 424 |
GO:0000187 | activation of MAPK activity | 2.15e-02 | 1.00e+00 | 3.145 | 2 | 2 | 90 |
GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway | 2.24e-02 | 1.00e+00 | 5.467 | 1 | 1 | 9 |
GO:0035259 | glucocorticoid receptor binding | 2.24e-02 | 1.00e+00 | 5.467 | 1 | 1 | 9 |
GO:0000302 | response to reactive oxygen species | 2.24e-02 | 1.00e+00 | 5.467 | 1 | 1 | 9 |
GO:0019509 | L-methionine biosynthetic process from methylthioadenosine | 2.24e-02 | 1.00e+00 | 5.467 | 1 | 1 | 9 |
GO:0006983 | ER overload response | 2.24e-02 | 1.00e+00 | 5.467 | 1 | 1 | 9 |
GO:0042834 | peptidoglycan binding | 2.24e-02 | 1.00e+00 | 5.467 | 1 | 1 | 9 |
GO:0071354 | cellular response to interleukin-6 | 2.24e-02 | 1.00e+00 | 5.467 | 1 | 1 | 9 |
GO:0045793 | positive regulation of cell size | 2.24e-02 | 1.00e+00 | 5.467 | 1 | 1 | 9 |
GO:0006782 | protoporphyrinogen IX biosynthetic process | 2.24e-02 | 1.00e+00 | 5.467 | 1 | 1 | 9 |
GO:0060765 | regulation of androgen receptor signaling pathway | 2.24e-02 | 1.00e+00 | 5.467 | 1 | 1 | 9 |
GO:0005832 | chaperonin-containing T-complex | 2.24e-02 | 1.00e+00 | 5.467 | 1 | 1 | 9 |
GO:0008134 | transcription factor binding | 2.37e-02 | 1.00e+00 | 2.279 | 3 | 6 | 246 |
GO:0001649 | osteoblast differentiation | 2.37e-02 | 1.00e+00 | 3.067 | 2 | 3 | 95 |
GO:0016070 | RNA metabolic process | 2.39e-02 | 1.00e+00 | 2.273 | 3 | 8 | 247 |
GO:0034142 | toll-like receptor 4 signaling pathway | 2.42e-02 | 1.00e+00 | 3.052 | 2 | 2 | 96 |
GO:0002199 | zona pellucida receptor complex | 2.48e-02 | 1.00e+00 | 5.315 | 1 | 1 | 10 |
GO:0045667 | regulation of osteoblast differentiation | 2.48e-02 | 1.00e+00 | 5.315 | 1 | 1 | 10 |
GO:0001518 | voltage-gated sodium channel complex | 2.48e-02 | 1.00e+00 | 5.315 | 1 | 1 | 10 |
GO:0032703 | negative regulation of interleukin-2 production | 2.48e-02 | 1.00e+00 | 5.315 | 1 | 1 | 10 |
GO:0016407 | acetyltransferase activity | 2.48e-02 | 1.00e+00 | 5.315 | 1 | 1 | 10 |
GO:0043194 | axon initial segment | 2.48e-02 | 1.00e+00 | 5.315 | 1 | 1 | 10 |
GO:0031274 | positive regulation of pseudopodium assembly | 2.48e-02 | 1.00e+00 | 5.315 | 1 | 1 | 10 |
GO:1900153 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 2.48e-02 | 1.00e+00 | 5.315 | 1 | 1 | 10 |
GO:0051382 | kinetochore assembly | 2.48e-02 | 1.00e+00 | 5.315 | 1 | 1 | 10 |
GO:0010944 | negative regulation of transcription by competitive promoter binding | 2.48e-02 | 1.00e+00 | 5.315 | 1 | 1 | 10 |
GO:0030877 | beta-catenin destruction complex | 2.48e-02 | 1.00e+00 | 5.315 | 1 | 1 | 10 |
GO:0071456 | cellular response to hypoxia | 2.51e-02 | 1.00e+00 | 3.022 | 2 | 2 | 98 |
GO:0005737 | cytoplasm | 2.64e-02 | 1.00e+00 | 0.680 | 16 | 43 | 3976 |
GO:0007417 | central nervous system development | 2.66e-02 | 1.00e+00 | 2.979 | 2 | 2 | 101 |
GO:0048387 | negative regulation of retinoic acid receptor signaling pathway | 2.73e-02 | 1.00e+00 | 5.177 | 1 | 1 | 11 |
GO:0030277 | maintenance of gastrointestinal epithelium | 2.73e-02 | 1.00e+00 | 5.177 | 1 | 1 | 11 |
GO:0031116 | positive regulation of microtubule polymerization | 2.73e-02 | 1.00e+00 | 5.177 | 1 | 1 | 11 |
GO:0032740 | positive regulation of interleukin-17 production | 2.73e-02 | 1.00e+00 | 5.177 | 1 | 1 | 11 |
GO:0004535 | poly(A)-specific ribonuclease activity | 2.73e-02 | 1.00e+00 | 5.177 | 1 | 1 | 11 |
GO:0033160 | positive regulation of protein import into nucleus, translocation | 2.73e-02 | 1.00e+00 | 5.177 | 1 | 1 | 11 |
GO:2000036 | regulation of stem cell maintenance | 2.73e-02 | 1.00e+00 | 5.177 | 1 | 1 | 11 |
GO:0042975 | peroxisome proliferator activated receptor binding | 2.73e-02 | 1.00e+00 | 5.177 | 1 | 1 | 11 |
GO:0060391 | positive regulation of SMAD protein import into nucleus | 2.73e-02 | 1.00e+00 | 5.177 | 1 | 1 | 11 |
GO:0045663 | positive regulation of myoblast differentiation | 2.73e-02 | 1.00e+00 | 5.177 | 1 | 1 | 11 |
GO:0051010 | microtubule plus-end binding | 2.73e-02 | 1.00e+00 | 5.177 | 1 | 2 | 11 |
GO:0045662 | negative regulation of myoblast differentiation | 2.73e-02 | 1.00e+00 | 5.177 | 1 | 1 | 11 |
GO:0019395 | fatty acid oxidation | 2.73e-02 | 1.00e+00 | 5.177 | 1 | 1 | 11 |
GO:0004707 | MAP kinase activity | 2.73e-02 | 1.00e+00 | 5.177 | 1 | 1 | 11 |
GO:0060213 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 2.73e-02 | 1.00e+00 | 5.177 | 1 | 1 | 11 |
GO:0043923 | positive regulation by host of viral transcription | 2.73e-02 | 1.00e+00 | 5.177 | 1 | 1 | 11 |
GO:0035413 | positive regulation of catenin import into nucleus | 2.73e-02 | 1.00e+00 | 5.177 | 1 | 1 | 11 |
GO:0007178 | transmembrane receptor protein serine/threonine kinase signaling pathway | 2.73e-02 | 1.00e+00 | 5.177 | 1 | 1 | 11 |
GO:0042770 | signal transduction in response to DNA damage | 2.73e-02 | 1.00e+00 | 5.177 | 1 | 1 | 11 |
GO:0032874 | positive regulation of stress-activated MAPK cascade | 2.97e-02 | 1.00e+00 | 5.052 | 1 | 1 | 12 |
GO:0070935 | 3'-UTR-mediated mRNA stabilization | 2.97e-02 | 1.00e+00 | 5.052 | 1 | 1 | 12 |
GO:0051146 | striated muscle cell differentiation | 2.97e-02 | 1.00e+00 | 5.052 | 1 | 1 | 12 |
GO:0045295 | gamma-catenin binding | 2.97e-02 | 1.00e+00 | 5.052 | 1 | 1 | 12 |
GO:0032695 | negative regulation of interleukin-12 production | 2.97e-02 | 1.00e+00 | 5.052 | 1 | 1 | 12 |
GO:0005838 | proteasome regulatory particle | 2.97e-02 | 1.00e+00 | 5.052 | 1 | 1 | 12 |
GO:0042581 | specific granule | 2.97e-02 | 1.00e+00 | 5.052 | 1 | 1 | 12 |
GO:0032886 | regulation of microtubule-based process | 2.97e-02 | 1.00e+00 | 5.052 | 1 | 1 | 12 |
GO:0002224 | toll-like receptor signaling pathway | 3.06e-02 | 1.00e+00 | 2.869 | 2 | 2 | 109 |
GO:0007140 | male meiosis | 3.22e-02 | 1.00e+00 | 4.936 | 1 | 1 | 13 |
GO:0043508 | negative regulation of JUN kinase activity | 3.22e-02 | 1.00e+00 | 4.936 | 1 | 1 | 13 |
GO:0009416 | response to light stimulus | 3.22e-02 | 1.00e+00 | 4.936 | 1 | 1 | 13 |
GO:0051019 | mitogen-activated protein kinase binding | 3.22e-02 | 1.00e+00 | 4.936 | 1 | 2 | 13 |
GO:0030914 | STAGA complex | 3.22e-02 | 1.00e+00 | 4.936 | 1 | 1 | 13 |
GO:0042974 | retinoic acid receptor binding | 3.22e-02 | 1.00e+00 | 4.936 | 1 | 1 | 13 |
GO:0004708 | MAP kinase kinase activity | 3.22e-02 | 1.00e+00 | 4.936 | 1 | 1 | 13 |
GO:0060766 | negative regulation of androgen receptor signaling pathway | 3.22e-02 | 1.00e+00 | 4.936 | 1 | 1 | 13 |
GO:0044295 | axonal growth cone | 3.22e-02 | 1.00e+00 | 4.936 | 1 | 1 | 13 |
GO:0030234 | enzyme regulator activity | 3.22e-02 | 1.00e+00 | 4.936 | 1 | 1 | 13 |
GO:0035198 | miRNA binding | 3.22e-02 | 1.00e+00 | 4.936 | 1 | 1 | 13 |
GO:0035371 | microtubule plus-end | 3.46e-02 | 1.00e+00 | 4.830 | 1 | 1 | 14 |
GO:0016045 | detection of bacterium | 3.46e-02 | 1.00e+00 | 4.830 | 1 | 1 | 14 |
GO:0070542 | response to fatty acid | 3.46e-02 | 1.00e+00 | 4.830 | 1 | 1 | 14 |
GO:0050905 | neuromuscular process | 3.46e-02 | 1.00e+00 | 4.830 | 1 | 1 | 14 |
GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process | 3.46e-02 | 1.00e+00 | 4.830 | 1 | 1 | 14 |
GO:0071480 | cellular response to gamma radiation | 3.46e-02 | 1.00e+00 | 4.830 | 1 | 1 | 14 |
GO:0004527 | exonuclease activity | 3.46e-02 | 1.00e+00 | 4.830 | 1 | 1 | 14 |
GO:0005095 | GTPase inhibitor activity | 3.46e-02 | 1.00e+00 | 4.830 | 1 | 1 | 14 |
GO:0032993 | protein-DNA complex | 3.46e-02 | 1.00e+00 | 4.830 | 1 | 1 | 14 |
GO:0001824 | blastocyst development | 3.70e-02 | 1.00e+00 | 4.730 | 1 | 1 | 15 |
GO:0030014 | CCR4-NOT complex | 3.70e-02 | 1.00e+00 | 4.730 | 1 | 1 | 15 |
GO:0060749 | mammary gland alveolus development | 3.70e-02 | 1.00e+00 | 4.730 | 1 | 1 | 15 |
GO:0042307 | positive regulation of protein import into nucleus | 3.70e-02 | 1.00e+00 | 4.730 | 1 | 2 | 15 |
GO:0005762 | mitochondrial large ribosomal subunit | 3.70e-02 | 1.00e+00 | 4.730 | 1 | 1 | 15 |
GO:1990090 | cellular response to nerve growth factor stimulus | 3.70e-02 | 1.00e+00 | 4.730 | 1 | 1 | 15 |
GO:0006325 | chromatin organization | 3.82e-02 | 1.00e+00 | 2.694 | 2 | 3 | 123 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 3.83e-02 | 1.00e+00 | 1.412 | 5 | 10 | 748 |
GO:0007026 | negative regulation of microtubule depolymerization | 3.95e-02 | 1.00e+00 | 4.637 | 1 | 2 | 16 |
GO:0033268 | node of Ranvier | 3.95e-02 | 1.00e+00 | 4.637 | 1 | 1 | 16 |
GO:0000132 | establishment of mitotic spindle orientation | 3.95e-02 | 1.00e+00 | 4.637 | 1 | 1 | 16 |
GO:0001056 | RNA polymerase III activity | 3.95e-02 | 1.00e+00 | 4.637 | 1 | 1 | 16 |
GO:0042176 | regulation of protein catabolic process | 3.95e-02 | 1.00e+00 | 4.637 | 1 | 1 | 16 |
GO:0005665 | DNA-directed RNA polymerase II, core complex | 3.95e-02 | 1.00e+00 | 4.637 | 1 | 1 | 16 |
GO:0016746 | transferase activity, transferring acyl groups | 3.95e-02 | 1.00e+00 | 4.637 | 1 | 2 | 16 |
GO:0051603 | proteolysis involved in cellular protein catabolic process | 3.95e-02 | 1.00e+00 | 4.637 | 1 | 1 | 16 |
GO:0046716 | muscle cell cellular homeostasis | 3.95e-02 | 1.00e+00 | 4.637 | 1 | 1 | 16 |
GO:0051276 | chromosome organization | 3.95e-02 | 1.00e+00 | 4.637 | 1 | 2 | 16 |
GO:0005248 | voltage-gated sodium channel activity | 3.95e-02 | 1.00e+00 | 4.637 | 1 | 1 | 16 |
GO:0007050 | cell cycle arrest | 3.99e-02 | 1.00e+00 | 2.660 | 2 | 3 | 126 |
GO:0043536 | positive regulation of blood vessel endothelial cell migration | 4.19e-02 | 1.00e+00 | 4.549 | 1 | 1 | 17 |
GO:0022624 | proteasome accessory complex | 4.19e-02 | 1.00e+00 | 4.549 | 1 | 1 | 17 |
GO:0001829 | trophectodermal cell differentiation | 4.19e-02 | 1.00e+00 | 4.549 | 1 | 2 | 17 |
GO:0005666 | DNA-directed RNA polymerase III complex | 4.19e-02 | 1.00e+00 | 4.549 | 1 | 1 | 17 |
GO:0070372 | regulation of ERK1 and ERK2 cascade | 4.19e-02 | 1.00e+00 | 4.549 | 1 | 1 | 17 |
GO:0044130 | negative regulation of growth of symbiont in host | 4.19e-02 | 1.00e+00 | 4.549 | 1 | 1 | 17 |
GO:0031122 | cytoplasmic microtubule organization | 4.43e-02 | 1.00e+00 | 4.467 | 1 | 1 | 18 |
GO:0045773 | positive regulation of axon extension | 4.43e-02 | 1.00e+00 | 4.467 | 1 | 1 | 18 |
GO:0033613 | activating transcription factor binding | 4.43e-02 | 1.00e+00 | 4.467 | 1 | 1 | 18 |
GO:0006386 | termination of RNA polymerase III transcription | 4.43e-02 | 1.00e+00 | 4.467 | 1 | 1 | 18 |
GO:0019228 | neuronal action potential | 4.43e-02 | 1.00e+00 | 4.467 | 1 | 1 | 18 |
GO:0050718 | positive regulation of interleukin-1 beta secretion | 4.43e-02 | 1.00e+00 | 4.467 | 1 | 1 | 18 |
GO:0006385 | transcription elongation from RNA polymerase III promoter | 4.43e-02 | 1.00e+00 | 4.467 | 1 | 1 | 18 |
GO:0031982 | vesicle | 4.45e-02 | 1.00e+00 | 2.571 | 2 | 2 | 134 |
GO:0032733 | positive regulation of interleukin-10 production | 4.67e-02 | 1.00e+00 | 4.389 | 1 | 2 | 19 |
GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity | 4.67e-02 | 1.00e+00 | 4.389 | 1 | 2 | 19 |
GO:0035257 | nuclear hormone receptor binding | 4.67e-02 | 1.00e+00 | 4.389 | 1 | 1 | 19 |
GO:0071549 | cellular response to dexamethasone stimulus | 4.91e-02 | 1.00e+00 | 4.315 | 1 | 1 | 20 |
GO:0002227 | innate immune response in mucosa | 4.91e-02 | 1.00e+00 | 4.315 | 1 | 1 | 20 |
GO:0051090 | regulation of sequence-specific DNA binding transcription factor activity | 4.91e-02 | 1.00e+00 | 4.315 | 1 | 1 | 20 |
GO:0006783 | heme biosynthetic process | 4.91e-02 | 1.00e+00 | 4.315 | 1 | 1 | 20 |
GO:0010942 | positive regulation of cell death | 4.91e-02 | 1.00e+00 | 4.315 | 1 | 1 | 20 |
GO:0001502 | cartilage condensation | 4.91e-02 | 1.00e+00 | 4.315 | 1 | 1 | 20 |
GO:0035924 | cellular response to vascular endothelial growth factor stimulus | 4.91e-02 | 1.00e+00 | 4.315 | 1 | 1 | 20 |
GO:0005680 | anaphase-promoting complex | 4.91e-02 | 1.00e+00 | 4.315 | 1 | 1 | 20 |
GO:0003677 | DNA binding | 4.92e-02 | 1.00e+00 | 1.044 | 7 | 16 | 1351 |
GO:0044822 | poly(A) RNA binding | 5.08e-02 | 1.00e+00 | 1.148 | 6 | 27 | 1078 |
GO:0048010 | vascular endothelial growth factor receptor signaling pathway | 5.15e-02 | 1.00e+00 | 4.245 | 1 | 1 | 21 |
GO:0045648 | positive regulation of erythrocyte differentiation | 5.15e-02 | 1.00e+00 | 4.245 | 1 | 1 | 21 |
GO:0032967 | positive regulation of collagen biosynthetic process | 5.15e-02 | 1.00e+00 | 4.245 | 1 | 1 | 21 |
GO:0045862 | positive regulation of proteolysis | 5.15e-02 | 1.00e+00 | 4.245 | 1 | 2 | 21 |
GO:0000123 | histone acetyltransferase complex | 5.15e-02 | 1.00e+00 | 4.245 | 1 | 2 | 21 |
GO:0004364 | glutathione transferase activity | 5.15e-02 | 1.00e+00 | 4.245 | 1 | 1 | 21 |
GO:0016575 | histone deacetylation | 5.15e-02 | 1.00e+00 | 4.245 | 1 | 1 | 21 |
GO:0032757 | positive regulation of interleukin-8 production | 5.15e-02 | 1.00e+00 | 4.245 | 1 | 1 | 21 |
GO:0009954 | proximal/distal pattern formation | 5.15e-02 | 1.00e+00 | 4.245 | 1 | 1 | 21 |
GO:0000281 | mitotic cytokinesis | 5.15e-02 | 1.00e+00 | 4.245 | 1 | 1 | 21 |
GO:0030316 | osteoclast differentiation | 5.39e-02 | 1.00e+00 | 4.177 | 1 | 1 | 22 |
GO:0005720 | nuclear heterochromatin | 5.39e-02 | 1.00e+00 | 4.177 | 1 | 1 | 22 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 5.39e-02 | 1.00e+00 | 4.177 | 1 | 1 | 22 |
GO:0001205 | RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription | 5.39e-02 | 1.00e+00 | 4.177 | 1 | 2 | 22 |
GO:0006915 | apoptotic process | 5.42e-02 | 1.00e+00 | 1.480 | 4 | 8 | 571 |
GO:0001666 | response to hypoxia | 5.45e-02 | 1.00e+00 | 2.408 | 2 | 3 | 150 |
GO:0042981 | regulation of apoptotic process | 5.51e-02 | 1.00e+00 | 2.398 | 2 | 3 | 151 |
GO:0005730 | nucleolus | 5.53e-02 | 1.00e+00 | 0.919 | 8 | 28 | 1684 |
GO:0031463 | Cul3-RING ubiquitin ligase complex | 5.62e-02 | 1.00e+00 | 4.113 | 1 | 1 | 23 |
GO:0045747 | positive regulation of Notch signaling pathway | 5.62e-02 | 1.00e+00 | 4.113 | 1 | 1 | 23 |
GO:1901687 | glutathione derivative biosynthetic process | 5.62e-02 | 1.00e+00 | 4.113 | 1 | 1 | 23 |
GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress | 5.86e-02 | 1.00e+00 | 4.052 | 1 | 1 | 24 |
GO:0048147 | negative regulation of fibroblast proliferation | 5.86e-02 | 1.00e+00 | 4.052 | 1 | 1 | 24 |
GO:0050766 | positive regulation of phagocytosis | 5.86e-02 | 1.00e+00 | 4.052 | 1 | 1 | 24 |
GO:0032689 | negative regulation of interferon-gamma production | 5.86e-02 | 1.00e+00 | 4.052 | 1 | 1 | 24 |
GO:0043388 | positive regulation of DNA binding | 5.86e-02 | 1.00e+00 | 4.052 | 1 | 1 | 24 |
GO:0006363 | termination of RNA polymerase I transcription | 5.86e-02 | 1.00e+00 | 4.052 | 1 | 1 | 24 |
GO:0043425 | bHLH transcription factor binding | 5.86e-02 | 1.00e+00 | 4.052 | 1 | 1 | 24 |
GO:2000379 | positive regulation of reactive oxygen species metabolic process | 5.86e-02 | 1.00e+00 | 4.052 | 1 | 1 | 24 |
GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening | 6.10e-02 | 1.00e+00 | 3.993 | 1 | 1 | 25 |
GO:0051059 | NF-kappaB binding | 6.10e-02 | 1.00e+00 | 3.993 | 1 | 2 | 25 |
GO:0071479 | cellular response to ionizing radiation | 6.10e-02 | 1.00e+00 | 3.993 | 1 | 1 | 25 |
GO:0086010 | membrane depolarization during action potential | 6.10e-02 | 1.00e+00 | 3.993 | 1 | 1 | 25 |
GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway | 6.10e-02 | 1.00e+00 | 3.993 | 1 | 1 | 25 |
GO:0003899 | DNA-directed RNA polymerase activity | 6.10e-02 | 1.00e+00 | 3.993 | 1 | 1 | 25 |
GO:0045296 | cadherin binding | 6.10e-02 | 1.00e+00 | 3.993 | 1 | 1 | 25 |
GO:0032735 | positive regulation of interleukin-12 production | 6.10e-02 | 1.00e+00 | 3.993 | 1 | 2 | 25 |
GO:0031047 | gene silencing by RNA | 6.34e-02 | 1.00e+00 | 3.936 | 1 | 2 | 26 |
GO:0070979 | protein K11-linked ubiquitination | 6.34e-02 | 1.00e+00 | 3.936 | 1 | 1 | 26 |
GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia | 6.34e-02 | 1.00e+00 | 3.936 | 1 | 1 | 26 |
GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic | 6.34e-02 | 1.00e+00 | 3.936 | 1 | 1 | 26 |
GO:0035329 | hippo signaling | 6.34e-02 | 1.00e+00 | 3.936 | 1 | 1 | 26 |
GO:0061025 | membrane fusion | 6.34e-02 | 1.00e+00 | 3.936 | 1 | 1 | 26 |
GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity | 6.34e-02 | 1.00e+00 | 3.936 | 1 | 1 | 26 |
GO:0051209 | release of sequestered calcium ion into cytosol | 6.34e-02 | 1.00e+00 | 3.936 | 1 | 2 | 26 |
GO:0000398 | mRNA splicing, via spliceosome | 6.45e-02 | 1.00e+00 | 2.271 | 2 | 9 | 165 |
GO:0051149 | positive regulation of muscle cell differentiation | 6.57e-02 | 1.00e+00 | 3.882 | 1 | 1 | 27 |
GO:0007422 | peripheral nervous system development | 6.57e-02 | 1.00e+00 | 3.882 | 1 | 1 | 27 |
GO:0000188 | inactivation of MAPK activity | 6.57e-02 | 1.00e+00 | 3.882 | 1 | 1 | 27 |
GO:0034080 | CENP-A containing nucleosome assembly | 6.57e-02 | 1.00e+00 | 3.882 | 1 | 2 | 27 |
GO:0048565 | digestive tract development | 6.57e-02 | 1.00e+00 | 3.882 | 1 | 1 | 27 |
GO:0007339 | binding of sperm to zona pellucida | 6.57e-02 | 1.00e+00 | 3.882 | 1 | 1 | 27 |
GO:0045087 | innate immune response | 6.78e-02 | 1.00e+00 | 1.370 | 4 | 4 | 616 |
GO:0000077 | DNA damage checkpoint | 6.81e-02 | 1.00e+00 | 3.830 | 1 | 1 | 28 |
GO:0000976 | transcription regulatory region sequence-specific DNA binding | 6.81e-02 | 1.00e+00 | 3.830 | 1 | 1 | 28 |
GO:0043967 | histone H4 acetylation | 6.81e-02 | 1.00e+00 | 3.830 | 1 | 1 | 28 |
GO:0003823 | antigen binding | 6.81e-02 | 1.00e+00 | 3.830 | 1 | 1 | 28 |
GO:0034612 | response to tumor necrosis factor | 6.81e-02 | 1.00e+00 | 3.830 | 1 | 1 | 28 |
GO:0007628 | adult walking behavior | 7.04e-02 | 1.00e+00 | 3.779 | 1 | 1 | 29 |
GO:0050714 | positive regulation of protein secretion | 7.04e-02 | 1.00e+00 | 3.779 | 1 | 1 | 29 |
GO:0071897 | DNA biosynthetic process | 7.04e-02 | 1.00e+00 | 3.779 | 1 | 1 | 29 |
GO:0005913 | cell-cell adherens junction | 7.04e-02 | 1.00e+00 | 3.779 | 1 | 1 | 29 |
GO:0006749 | glutathione metabolic process | 7.04e-02 | 1.00e+00 | 3.779 | 1 | 1 | 29 |
GO:0031663 | lipopolysaccharide-mediated signaling pathway | 7.04e-02 | 1.00e+00 | 3.779 | 1 | 1 | 29 |
GO:0006360 | transcription from RNA polymerase I promoter | 7.27e-02 | 1.00e+00 | 3.730 | 1 | 1 | 30 |
GO:0043330 | response to exogenous dsRNA | 7.27e-02 | 1.00e+00 | 3.730 | 1 | 1 | 30 |
GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling | 7.27e-02 | 1.00e+00 | 3.730 | 1 | 1 | 30 |
GO:0006370 | 7-methylguanosine mRNA capping | 7.27e-02 | 1.00e+00 | 3.730 | 1 | 2 | 30 |
GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 7.27e-02 | 1.00e+00 | 3.730 | 1 | 1 | 30 |
GO:0005667 | transcription factor complex | 7.35e-02 | 1.00e+00 | 2.161 | 2 | 3 | 178 |
GO:0070373 | negative regulation of ERK1 and ERK2 cascade | 7.51e-02 | 1.00e+00 | 3.683 | 1 | 1 | 31 |
GO:0006139 | nucleobase-containing compound metabolic process | 7.74e-02 | 1.00e+00 | 3.637 | 1 | 1 | 32 |
GO:0042594 | response to starvation | 7.74e-02 | 1.00e+00 | 3.637 | 1 | 3 | 32 |
GO:0043491 | protein kinase B signaling | 7.74e-02 | 1.00e+00 | 3.637 | 1 | 1 | 32 |
GO:0002062 | chondrocyte differentiation | 7.74e-02 | 1.00e+00 | 3.637 | 1 | 2 | 32 |
GO:1903507 | negative regulation of nucleic acid-templated transcription | 7.74e-02 | 1.00e+00 | 3.637 | 1 | 1 | 32 |
GO:0009953 | dorsal/ventral pattern formation | 7.74e-02 | 1.00e+00 | 3.637 | 1 | 1 | 32 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 7.79e-02 | 1.00e+00 | 2.113 | 2 | 5 | 184 |
GO:0070830 | tight junction assembly | 7.97e-02 | 1.00e+00 | 3.592 | 1 | 1 | 33 |
GO:0033077 | T cell differentiation in thymus | 7.97e-02 | 1.00e+00 | 3.592 | 1 | 1 | 33 |
GO:0001104 | RNA polymerase II transcription cofactor activity | 7.97e-02 | 1.00e+00 | 3.592 | 1 | 3 | 33 |
GO:0043407 | negative regulation of MAP kinase activity | 8.20e-02 | 1.00e+00 | 3.549 | 1 | 1 | 34 |
GO:0042692 | muscle cell differentiation | 8.20e-02 | 1.00e+00 | 3.549 | 1 | 1 | 34 |
GO:0043547 | positive regulation of GTPase activity | 8.23e-02 | 1.00e+00 | 2.067 | 2 | 2 | 190 |
GO:0071333 | cellular response to glucose stimulus | 8.44e-02 | 1.00e+00 | 3.508 | 1 | 1 | 35 |
GO:2001237 | negative regulation of extrinsic apoptotic signaling pathway | 8.44e-02 | 1.00e+00 | 3.508 | 1 | 1 | 35 |
GO:0016592 | mediator complex | 8.44e-02 | 1.00e+00 | 3.508 | 1 | 5 | 35 |
GO:0001942 | hair follicle development | 8.44e-02 | 1.00e+00 | 3.508 | 1 | 1 | 35 |
GO:0048538 | thymus development | 8.67e-02 | 1.00e+00 | 3.467 | 1 | 1 | 36 |
GO:0032755 | positive regulation of interleukin-6 production | 8.67e-02 | 1.00e+00 | 3.467 | 1 | 2 | 36 |
GO:0006446 | regulation of translational initiation | 8.67e-02 | 1.00e+00 | 3.467 | 1 | 2 | 36 |
GO:0001102 | RNA polymerase II activating transcription factor binding | 8.90e-02 | 1.00e+00 | 3.427 | 1 | 1 | 37 |
GO:0051084 | 'de novo' posttranslational protein folding | 8.90e-02 | 1.00e+00 | 3.427 | 1 | 1 | 37 |
GO:0032760 | positive regulation of tumor necrosis factor production | 8.90e-02 | 1.00e+00 | 3.427 | 1 | 1 | 37 |
GO:0001541 | ovarian follicle development | 8.90e-02 | 1.00e+00 | 3.427 | 1 | 1 | 37 |
GO:0001756 | somitogenesis | 9.13e-02 | 1.00e+00 | 3.389 | 1 | 1 | 38 |
GO:0050681 | androgen receptor binding | 9.13e-02 | 1.00e+00 | 3.389 | 1 | 1 | 38 |
GO:0051781 | positive regulation of cell division | 9.35e-02 | 1.00e+00 | 3.351 | 1 | 1 | 39 |
GO:0032092 | positive regulation of protein binding | 9.35e-02 | 1.00e+00 | 3.351 | 1 | 1 | 39 |
GO:0006383 | transcription from RNA polymerase III promoter | 9.35e-02 | 1.00e+00 | 3.351 | 1 | 3 | 39 |
GO:0031490 | chromatin DNA binding | 9.35e-02 | 1.00e+00 | 3.351 | 1 | 1 | 39 |
GO:0071407 | cellular response to organic cyclic compound | 9.35e-02 | 1.00e+00 | 3.351 | 1 | 3 | 39 |
GO:0046332 | SMAD binding | 9.58e-02 | 1.00e+00 | 3.315 | 1 | 1 | 40 |
GO:0001701 | in utero embryonic development | 9.75e-02 | 1.00e+00 | 1.923 | 2 | 2 | 210 |
GO:0005881 | cytoplasmic microtubule | 9.81e-02 | 1.00e+00 | 3.279 | 1 | 2 | 41 |
GO:0070301 | cellular response to hydrogen peroxide | 9.81e-02 | 1.00e+00 | 3.279 | 1 | 1 | 41 |
GO:0045785 | positive regulation of cell adhesion | 9.81e-02 | 1.00e+00 | 3.279 | 1 | 1 | 41 |
GO:0051259 | protein oligomerization | 9.81e-02 | 1.00e+00 | 3.279 | 1 | 1 | 41 |
GO:0071320 | cellular response to cAMP | 1.00e-01 | 1.00e+00 | 3.245 | 1 | 1 | 42 |
GO:0035914 | skeletal muscle cell differentiation | 1.00e-01 | 1.00e+00 | 3.245 | 1 | 1 | 42 |
GO:0035872 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway | 1.03e-01 | 1.00e+00 | 3.211 | 1 | 1 | 43 |
GO:0004402 | histone acetyltransferase activity | 1.03e-01 | 1.00e+00 | 3.211 | 1 | 1 | 43 |
GO:0006892 | post-Golgi vesicle-mediated transport | 1.05e-01 | 1.00e+00 | 3.177 | 1 | 1 | 44 |
GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding | 1.05e-01 | 1.00e+00 | 3.177 | 1 | 1 | 44 |
GO:0050434 | positive regulation of viral transcription | 1.05e-01 | 1.00e+00 | 3.177 | 1 | 2 | 44 |
GO:0043966 | histone H3 acetylation | 1.07e-01 | 1.00e+00 | 3.145 | 1 | 1 | 45 |
GO:0016328 | lateral plasma membrane | 1.09e-01 | 1.00e+00 | 3.113 | 1 | 1 | 46 |
GO:0044297 | cell body | 1.09e-01 | 1.00e+00 | 3.113 | 1 | 1 | 46 |
GO:0043525 | positive regulation of neuron apoptotic process | 1.09e-01 | 1.00e+00 | 3.113 | 1 | 2 | 46 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 1.09e-01 | 1.00e+00 | 3.113 | 1 | 1 | 46 |
GO:0045727 | positive regulation of translation | 1.09e-01 | 1.00e+00 | 3.113 | 1 | 2 | 46 |
GO:0001047 | core promoter binding | 1.09e-01 | 1.00e+00 | 3.113 | 1 | 2 | 46 |
GO:0050727 | regulation of inflammatory response | 1.12e-01 | 1.00e+00 | 3.082 | 1 | 1 | 47 |
GO:0006921 | cellular component disassembly involved in execution phase of apoptosis | 1.12e-01 | 1.00e+00 | 3.082 | 1 | 1 | 47 |
GO:0048511 | rhythmic process | 1.12e-01 | 1.00e+00 | 3.082 | 1 | 2 | 47 |
GO:0008380 | RNA splicing | 1.15e-01 | 1.00e+00 | 1.779 | 2 | 14 | 232 |
GO:0050830 | defense response to Gram-positive bacterium | 1.16e-01 | 1.00e+00 | 3.022 | 1 | 1 | 49 |
GO:0006521 | regulation of cellular amino acid metabolic process | 1.18e-01 | 1.00e+00 | 2.993 | 1 | 2 | 50 |
GO:0035690 | cellular response to drug | 1.18e-01 | 1.00e+00 | 2.993 | 1 | 2 | 50 |
GO:0005778 | peroxisomal membrane | 1.18e-01 | 1.00e+00 | 2.993 | 1 | 2 | 50 |
GO:0005524 | ATP binding | 1.20e-01 | 1.00e+00 | 0.819 | 6 | 13 | 1354 |
GO:0006986 | response to unfolded protein | 1.21e-01 | 1.00e+00 | 2.964 | 1 | 2 | 51 |
GO:0003713 | transcription coactivator activity | 1.21e-01 | 1.00e+00 | 1.736 | 2 | 7 | 239 |
GO:0000902 | cell morphogenesis | 1.21e-01 | 1.00e+00 | 2.964 | 1 | 1 | 51 |
GO:0045732 | positive regulation of protein catabolic process | 1.21e-01 | 1.00e+00 | 2.964 | 1 | 1 | 51 |
GO:0045454 | cell redox homeostasis | 1.23e-01 | 1.00e+00 | 2.936 | 1 | 1 | 52 |
GO:0031398 | positive regulation of protein ubiquitination | 1.23e-01 | 1.00e+00 | 2.936 | 1 | 1 | 52 |
GO:0034976 | response to endoplasmic reticulum stress | 1.23e-01 | 1.00e+00 | 2.936 | 1 | 1 | 52 |
GO:0009611 | response to wounding | 1.25e-01 | 1.00e+00 | 2.909 | 1 | 1 | 53 |
GO:0006952 | defense response | 1.25e-01 | 1.00e+00 | 2.909 | 1 | 1 | 53 |
GO:0060041 | retina development in camera-type eye | 1.25e-01 | 1.00e+00 | 2.909 | 1 | 1 | 53 |
GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 1.25e-01 | 1.00e+00 | 2.909 | 1 | 2 | 53 |
GO:0007399 | nervous system development | 1.26e-01 | 1.00e+00 | 1.700 | 2 | 3 | 245 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 1.27e-01 | 1.00e+00 | 2.882 | 1 | 1 | 54 |
GO:0007623 | circadian rhythm | 1.27e-01 | 1.00e+00 | 2.882 | 1 | 2 | 54 |
GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process | 1.27e-01 | 1.00e+00 | 2.882 | 1 | 1 | 54 |
GO:0050679 | positive regulation of epithelial cell proliferation | 1.27e-01 | 1.00e+00 | 2.882 | 1 | 1 | 54 |
GO:0002039 | p53 binding | 1.29e-01 | 1.00e+00 | 2.856 | 1 | 3 | 55 |
GO:0008233 | peptidase activity | 1.29e-01 | 1.00e+00 | 2.856 | 1 | 1 | 55 |
GO:0051592 | response to calcium ion | 1.29e-01 | 1.00e+00 | 2.856 | 1 | 1 | 55 |
GO:0006814 | sodium ion transport | 1.29e-01 | 1.00e+00 | 2.856 | 1 | 1 | 55 |
GO:0046330 | positive regulation of JNK cascade | 1.29e-01 | 1.00e+00 | 2.856 | 1 | 1 | 55 |
GO:0000932 | cytoplasmic mRNA processing body | 1.32e-01 | 1.00e+00 | 2.830 | 1 | 2 | 56 |
GO:0071300 | cellular response to retinoic acid | 1.32e-01 | 1.00e+00 | 2.830 | 1 | 1 | 56 |
GO:0043627 | response to estrogen | 1.34e-01 | 1.00e+00 | 2.804 | 1 | 1 | 57 |
GO:0006879 | cellular iron ion homeostasis | 1.34e-01 | 1.00e+00 | 2.804 | 1 | 1 | 57 |
GO:0000502 | proteasome complex | 1.36e-01 | 1.00e+00 | 2.779 | 1 | 2 | 58 |
GO:0035725 | sodium ion transmembrane transport | 1.36e-01 | 1.00e+00 | 2.779 | 1 | 1 | 58 |
GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity | 1.38e-01 | 1.00e+00 | 2.754 | 1 | 2 | 59 |
GO:0006396 | RNA processing | 1.40e-01 | 1.00e+00 | 2.730 | 1 | 4 | 60 |
GO:0006987 | activation of signaling protein activity involved in unfolded protein response | 1.45e-01 | 1.00e+00 | 2.683 | 1 | 2 | 62 |
GO:0000776 | kinetochore | 1.47e-01 | 1.00e+00 | 2.660 | 1 | 4 | 63 |
GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process | 1.47e-01 | 1.00e+00 | 2.660 | 1 | 1 | 63 |
GO:0006417 | regulation of translation | 1.47e-01 | 1.00e+00 | 2.660 | 1 | 1 | 63 |
GO:0019903 | protein phosphatase binding | 1.47e-01 | 1.00e+00 | 2.660 | 1 | 1 | 63 |
GO:0032088 | negative regulation of NF-kappaB transcription factor activity | 1.49e-01 | 1.00e+00 | 2.637 | 1 | 2 | 64 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 1.51e-01 | 1.00e+00 | 2.615 | 1 | 3 | 65 |
GO:0006469 | negative regulation of protein kinase activity | 1.51e-01 | 1.00e+00 | 2.615 | 1 | 2 | 65 |
GO:0006357 | regulation of transcription from RNA polymerase II promoter | 1.52e-01 | 1.00e+00 | 1.534 | 2 | 4 | 275 |
GO:0009636 | response to toxic substance | 1.53e-01 | 1.00e+00 | 2.592 | 1 | 1 | 66 |
GO:0007409 | axonogenesis | 1.53e-01 | 1.00e+00 | 2.592 | 1 | 1 | 66 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 1.55e-01 | 1.00e+00 | 2.571 | 1 | 3 | 67 |
GO:0006338 | chromatin remodeling | 1.58e-01 | 1.00e+00 | 2.549 | 1 | 1 | 68 |
GO:0003697 | single-stranded DNA binding | 1.60e-01 | 1.00e+00 | 2.528 | 1 | 2 | 69 |
GO:0018105 | peptidyl-serine phosphorylation | 1.60e-01 | 1.00e+00 | 2.528 | 1 | 1 | 69 |
GO:0006289 | nucleotide-excision repair | 1.60e-01 | 1.00e+00 | 2.528 | 1 | 1 | 69 |
GO:0006887 | exocytosis | 1.60e-01 | 1.00e+00 | 2.528 | 1 | 1 | 69 |
GO:0000786 | nucleosome | 1.62e-01 | 1.00e+00 | 2.508 | 1 | 1 | 70 |
GO:0042742 | defense response to bacterium | 1.62e-01 | 1.00e+00 | 2.508 | 1 | 1 | 70 |
GO:0019899 | enzyme binding | 1.63e-01 | 1.00e+00 | 1.467 | 2 | 3 | 288 |
GO:0032587 | ruffle membrane | 1.66e-01 | 1.00e+00 | 2.467 | 1 | 1 | 72 |
GO:0010468 | regulation of gene expression | 1.66e-01 | 1.00e+00 | 2.467 | 1 | 1 | 72 |
GO:0007584 | response to nutrient | 1.66e-01 | 1.00e+00 | 2.467 | 1 | 1 | 72 |
GO:0008021 | synaptic vesicle | 1.68e-01 | 1.00e+00 | 2.447 | 1 | 2 | 73 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 1.68e-01 | 1.00e+00 | 2.447 | 1 | 2 | 73 |
GO:0042826 | histone deacetylase binding | 1.70e-01 | 1.00e+00 | 2.427 | 1 | 2 | 74 |
GO:0070062 | extracellular vesicular exosome | 1.71e-01 | 1.00e+00 | 0.510 | 9 | 15 | 2516 |
GO:0007265 | Ras protein signal transduction | 1.72e-01 | 1.00e+00 | 2.408 | 1 | 2 | 75 |
GO:0060070 | canonical Wnt signaling pathway | 1.72e-01 | 1.00e+00 | 2.408 | 1 | 2 | 75 |
GO:0050731 | positive regulation of peptidyl-tyrosine phosphorylation | 1.72e-01 | 1.00e+00 | 2.408 | 1 | 1 | 75 |
GO:0016567 | protein ubiquitination | 1.73e-01 | 1.00e+00 | 1.413 | 2 | 5 | 299 |
GO:0005743 | mitochondrial inner membrane | 1.74e-01 | 1.00e+00 | 1.408 | 2 | 3 | 300 |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 1.74e-01 | 1.00e+00 | 2.389 | 1 | 2 | 76 |
GO:0043234 | protein complex | 1.74e-01 | 1.00e+00 | 1.408 | 2 | 4 | 300 |
GO:0030324 | lung development | 1.74e-01 | 1.00e+00 | 2.389 | 1 | 1 | 76 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 1.76e-01 | 1.00e+00 | 2.370 | 1 | 2 | 77 |
GO:0008584 | male gonad development | 1.76e-01 | 1.00e+00 | 2.370 | 1 | 1 | 77 |
GO:0030182 | neuron differentiation | 1.76e-01 | 1.00e+00 | 2.370 | 1 | 1 | 77 |
GO:0000981 | sequence-specific DNA binding RNA polymerase II transcription factor activity | 1.76e-01 | 1.00e+00 | 2.370 | 1 | 2 | 77 |
GO:0001822 | kidney development | 1.81e-01 | 1.00e+00 | 2.333 | 1 | 2 | 79 |
GO:0006334 | nucleosome assembly | 1.81e-01 | 1.00e+00 | 2.333 | 1 | 3 | 79 |
GO:0071013 | catalytic step 2 spliceosome | 1.81e-01 | 1.00e+00 | 2.333 | 1 | 3 | 79 |
GO:0030968 | endoplasmic reticulum unfolded protein response | 1.85e-01 | 1.00e+00 | 2.297 | 1 | 2 | 81 |
GO:0001889 | liver development | 1.87e-01 | 1.00e+00 | 2.279 | 1 | 2 | 82 |
GO:0035556 | intracellular signal transduction | 1.89e-01 | 1.00e+00 | 1.329 | 2 | 2 | 317 |
GO:0007517 | muscle organ development | 1.89e-01 | 1.00e+00 | 2.262 | 1 | 1 | 83 |
GO:0009952 | anterior/posterior pattern specification | 1.91e-01 | 1.00e+00 | 2.245 | 1 | 2 | 84 |
GO:0019901 | protein kinase binding | 1.92e-01 | 1.00e+00 | 1.315 | 2 | 4 | 320 |
GO:0009653 | anatomical structure morphogenesis | 1.97e-01 | 1.00e+00 | 2.194 | 1 | 1 | 87 |
GO:0045471 | response to ethanol | 1.99e-01 | 1.00e+00 | 2.177 | 1 | 1 | 88 |
GO:0009887 | organ morphogenesis | 2.01e-01 | 1.00e+00 | 2.161 | 1 | 1 | 89 |
GO:0008283 | cell proliferation | 2.02e-01 | 1.00e+00 | 1.266 | 2 | 3 | 331 |
GO:0006351 | transcription, DNA-templated | 2.03e-01 | 1.00e+00 | 0.592 | 6 | 17 | 1585 |
GO:0000922 | spindle pole | 2.05e-01 | 1.00e+00 | 2.129 | 1 | 1 | 91 |
GO:0006928 | cellular component movement | 2.07e-01 | 1.00e+00 | 2.113 | 1 | 1 | 92 |
GO:0016363 | nuclear matrix | 2.07e-01 | 1.00e+00 | 2.113 | 1 | 5 | 92 |
GO:0005923 | tight junction | 2.07e-01 | 1.00e+00 | 2.113 | 1 | 1 | 92 |
GO:0051091 | positive regulation of sequence-specific DNA binding transcription factor activity | 2.09e-01 | 1.00e+00 | 2.098 | 1 | 2 | 93 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 2.11e-01 | 1.00e+00 | 2.082 | 1 | 2 | 94 |
GO:0005770 | late endosome | 2.11e-01 | 1.00e+00 | 2.082 | 1 | 1 | 94 |
GO:0051082 | unfolded protein binding | 2.13e-01 | 1.00e+00 | 2.067 | 1 | 3 | 95 |
GO:0007165 | signal transduction | 2.14e-01 | 1.00e+00 | 0.745 | 4 | 8 | 950 |
GO:0030018 | Z disc | 2.19e-01 | 1.00e+00 | 2.022 | 1 | 2 | 98 |
GO:0003723 | RNA binding | 2.24e-01 | 1.00e+00 | 1.165 | 2 | 15 | 355 |
GO:0051726 | regulation of cell cycle | 2.27e-01 | 1.00e+00 | 1.964 | 1 | 4 | 102 |
GO:0043565 | sequence-specific DNA binding | 2.33e-01 | 1.00e+00 | 1.125 | 2 | 3 | 365 |
GO:0008285 | negative regulation of cell proliferation | 2.35e-01 | 1.00e+00 | 1.117 | 2 | 4 | 367 |
GO:0016023 | cytoplasmic membrane-bounded vesicle | 2.37e-01 | 1.00e+00 | 1.895 | 1 | 1 | 107 |
GO:0001934 | positive regulation of protein phosphorylation | 2.39e-01 | 1.00e+00 | 1.882 | 1 | 1 | 108 |
GO:0006935 | chemotaxis | 2.39e-01 | 1.00e+00 | 1.882 | 1 | 1 | 108 |
GO:0070374 | positive regulation of ERK1 and ERK2 cascade | 2.42e-01 | 1.00e+00 | 1.856 | 1 | 1 | 110 |
GO:0006461 | protein complex assembly | 2.44e-01 | 1.00e+00 | 1.842 | 1 | 2 | 111 |
GO:0007605 | sensory perception of sound | 2.44e-01 | 1.00e+00 | 1.842 | 1 | 1 | 111 |
GO:0034765 | regulation of ion transmembrane transport | 2.48e-01 | 1.00e+00 | 1.817 | 1 | 1 | 113 |
GO:0030308 | negative regulation of cell growth | 2.48e-01 | 1.00e+00 | 1.817 | 1 | 2 | 113 |
GO:0030529 | ribonucleoprotein complex | 2.50e-01 | 1.00e+00 | 1.804 | 1 | 6 | 114 |
GO:0000209 | protein polyubiquitination | 2.54e-01 | 1.00e+00 | 1.779 | 1 | 5 | 116 |
GO:0004252 | serine-type endopeptidase activity | 2.59e-01 | 1.00e+00 | 1.742 | 1 | 1 | 119 |
GO:0006006 | glucose metabolic process | 2.59e-01 | 1.00e+00 | 1.742 | 1 | 1 | 119 |
GO:0032496 | response to lipopolysaccharide | 2.65e-01 | 1.00e+00 | 1.706 | 1 | 1 | 122 |
GO:0003676 | nucleic acid binding | 2.65e-01 | 1.00e+00 | 1.706 | 1 | 2 | 122 |
GO:0046982 | protein heterodimerization activity | 2.65e-01 | 1.00e+00 | 0.997 | 2 | 3 | 399 |
GO:0051092 | positive regulation of NF-kappaB transcription factor activity | 2.71e-01 | 1.00e+00 | 1.671 | 1 | 1 | 125 |
GO:0007219 | Notch signaling pathway | 2.71e-01 | 1.00e+00 | 1.671 | 1 | 2 | 125 |
GO:0006805 | xenobiotic metabolic process | 2.78e-01 | 1.00e+00 | 1.626 | 1 | 1 | 129 |
GO:0008270 | zinc ion binding | 2.79e-01 | 1.00e+00 | 0.578 | 4 | 11 | 1067 |
GO:0030027 | lamellipodium | 2.80e-01 | 1.00e+00 | 1.615 | 1 | 1 | 130 |
GO:0030335 | positive regulation of cell migration | 2.80e-01 | 1.00e+00 | 1.615 | 1 | 2 | 130 |
GO:0016477 | cell migration | 2.82e-01 | 1.00e+00 | 1.603 | 1 | 2 | 131 |
GO:0009986 | cell surface | 2.87e-01 | 1.00e+00 | 0.916 | 2 | 4 | 422 |
GO:0000086 | G2/M transition of mitotic cell cycle | 2.93e-01 | 1.00e+00 | 1.539 | 1 | 3 | 137 |
GO:0043066 | negative regulation of apoptotic process | 2.97e-01 | 1.00e+00 | 0.879 | 2 | 5 | 433 |
GO:0045202 | synapse | 2.98e-01 | 1.00e+00 | 1.508 | 1 | 1 | 140 |
GO:0007507 | heart development | 3.00e-01 | 1.00e+00 | 1.497 | 1 | 2 | 141 |
GO:0016055 | Wnt signaling pathway | 3.00e-01 | 1.00e+00 | 1.497 | 1 | 3 | 141 |
GO:0061024 | membrane organization | 3.08e-01 | 1.00e+00 | 1.447 | 1 | 1 | 146 |
GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling | 3.12e-01 | 1.00e+00 | 1.427 | 1 | 1 | 148 |
GO:0010628 | positive regulation of gene expression | 3.14e-01 | 1.00e+00 | 1.418 | 1 | 2 | 149 |
GO:0006457 | protein folding | 3.14e-01 | 1.00e+00 | 1.418 | 1 | 1 | 149 |
GO:0007166 | cell surface receptor signaling pathway | 3.14e-01 | 1.00e+00 | 1.418 | 1 | 1 | 149 |
GO:0008017 | microtubule binding | 3.15e-01 | 1.00e+00 | 1.408 | 1 | 4 | 150 |
GO:0051260 | protein homooligomerization | 3.15e-01 | 1.00e+00 | 1.408 | 1 | 1 | 150 |
GO:0000082 | G1/S transition of mitotic cell cycle | 3.15e-01 | 1.00e+00 | 1.408 | 1 | 4 | 150 |
GO:0043005 | neuron projection | 3.34e-01 | 1.00e+00 | 1.306 | 1 | 4 | 161 |
GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 3.46e-01 | 1.00e+00 | 1.245 | 1 | 3 | 168 |
GO:0045893 | positive regulation of transcription, DNA-templated | 3.47e-01 | 1.00e+00 | 0.709 | 2 | 6 | 487 |
GO:0042802 | identical protein binding | 3.51e-01 | 1.00e+00 | 0.697 | 2 | 6 | 491 |
GO:0034641 | cellular nitrogen compound metabolic process | 3.61e-01 | 1.00e+00 | 1.169 | 1 | 3 | 177 |
GO:0007049 | cell cycle | 3.61e-01 | 1.00e+00 | 1.169 | 1 | 4 | 177 |
GO:0031625 | ubiquitin protein ligase binding | 3.66e-01 | 1.00e+00 | 1.145 | 1 | 2 | 180 |
GO:0032403 | protein complex binding | 3.74e-01 | 1.00e+00 | 1.106 | 1 | 2 | 185 |
GO:0001525 | angiogenesis | 3.97e-01 | 1.00e+00 | 0.993 | 1 | 1 | 200 |
GO:0030168 | platelet activation | 4.05e-01 | 1.00e+00 | 0.957 | 1 | 1 | 205 |
GO:0044281 | small molecule metabolic process | 4.12e-01 | 1.00e+00 | 0.298 | 4 | 12 | 1295 |
GO:0004871 | signal transducer activity | 4.21e-01 | 1.00e+00 | 0.882 | 1 | 1 | 216 |
GO:0005622 | intracellular | 4.36e-01 | 1.00e+00 | 0.817 | 1 | 2 | 226 |
GO:0007067 | mitotic nuclear division | 4.43e-01 | 1.00e+00 | 0.785 | 1 | 4 | 231 |
GO:0005759 | mitochondrial matrix | 4.46e-01 | 1.00e+00 | 0.773 | 1 | 4 | 233 |
GO:0016020 | membrane | 4.50e-01 | 1.00e+00 | 0.189 | 5 | 27 | 1746 |
GO:0030425 | dendrite | 4.56e-01 | 1.00e+00 | 0.730 | 1 | 1 | 240 |
GO:0043025 | neuronal cell body | 4.75e-01 | 1.00e+00 | 0.648 | 1 | 3 | 254 |
GO:0004842 | ubiquitin-protein transferase activity | 4.77e-01 | 1.00e+00 | 0.637 | 1 | 5 | 256 |
GO:0005874 | microtubule | 4.80e-01 | 1.00e+00 | 0.626 | 1 | 3 | 258 |
GO:0006281 | DNA repair | 4.88e-01 | 1.00e+00 | 0.592 | 1 | 4 | 264 |
GO:0048011 | neurotrophin TRK receptor signaling pathway | 5.00e-01 | 1.00e+00 | 0.544 | 1 | 2 | 273 |
GO:0043065 | positive regulation of apoptotic process | 5.01e-01 | 1.00e+00 | 0.539 | 1 | 3 | 274 |
GO:0005856 | cytoskeleton | 5.46e-01 | 1.00e+00 | 0.356 | 1 | 2 | 311 |
GO:0004674 | protein serine/threonine kinase activity | 5.47e-01 | 1.00e+00 | 0.351 | 1 | 2 | 312 |
GO:0030154 | cell differentiation | 5.62e-01 | 1.00e+00 | 0.293 | 1 | 2 | 325 |
GO:0007411 | axon guidance | 5.64e-01 | 1.00e+00 | 0.284 | 1 | 2 | 327 |
GO:0005525 | GTP binding | 5.65e-01 | 1.00e+00 | 0.279 | 1 | 5 | 328 |
GO:0005813 | centrosome | 5.78e-01 | 1.00e+00 | 0.232 | 1 | 4 | 339 |
GO:0030054 | cell junction | 5.96e-01 | 1.00e+00 | 0.161 | 1 | 3 | 356 |
GO:0015031 | protein transport | 5.97e-01 | 1.00e+00 | 0.157 | 1 | 2 | 357 |
GO:0005925 | focal adhesion | 6.10e-01 | 1.00e+00 | 0.106 | 1 | 2 | 370 |
GO:0007155 | cell adhesion | 6.24e-01 | 1.00e+00 | 0.052 | 1 | 2 | 384 |
GO:0006508 | proteolysis | 6.48e-01 | 1.00e+00 | -0.043 | 1 | 2 | 410 |
GO:0007596 | blood coagulation | 6.94e-01 | 1.00e+00 | -0.221 | 1 | 1 | 464 |
GO:0005615 | extracellular space | 7.30e-01 | 1.00e+00 | -0.343 | 2 | 4 | 1010 |
GO:0055085 | transmembrane transport | 7.31e-01 | 1.00e+00 | -0.369 | 1 | 5 | 514 |
GO:0005886 | plasma membrane | 7.40e-01 | 1.00e+00 | -0.247 | 6 | 14 | 2834 |
GO:0005789 | endoplasmic reticulum membrane | 8.04e-01 | 1.00e+00 | -0.676 | 1 | 2 | 636 |
GO:0046872 | metal ion binding | 8.94e-01 | 1.00e+00 | -0.880 | 2 | 6 | 1465 |
GO:0005887 | integral component of plasma membrane | 9.17e-01 | 1.00e+00 | -1.272 | 1 | 1 | 961 |
GO:0016021 | integral component of membrane | 9.90e-01 | 1.00e+00 | -1.641 | 2 | 7 | 2483 |